Detalles de la búsqueda
1.
[Successful treatment of traumatic intramuscular hemorrhage with coagulation factor VIII replacement in a patient with congenital hemophilia A with decreased inhibitor activity by emicizumab therapy].
Rinsho Ketsueki
; 64(3): 198-202, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-37019673
2.
A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy.
Pharmacogenomics J
; 22(4): 241-246, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35752658
3.
A Genome-Wide Association Study Predicts the Onset of Dysgeusia Due to Anti-cancer Drug Treatment.
Biol Pharm Bull
; 45(1): 114-117, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657909
4.
[Clinical features of five cases of acquired factor V deficiency].
Rinsho Ketsueki
; 63(7): 733-739, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35922940
5.
[Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy].
Rinsho Ketsueki
; 63(6): 536-543, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35831185
6.
TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma.
Haematologica
; 106(5): 1401-1413, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273474
7.
Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity.
Br J Haematol
; 180(2): 246-258, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29327347
8.
Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of Cryptosporidium oocysts by intestinal biopsies.
Transpl Infect Dis
; 20(2): e12826, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29277954
9.
Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome.
J Infect Chemother
; 24(5): 389-392, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29428565
10.
Frequent bleeding symptoms associated with autoimmune acquired factor XIII/13 deficiency due to anti-factor XIII A and B subunit antibodies.
Am J Hematol
; 97(11): 1497-1500, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35957554
11.
[Analysis of long-term survivors with cardiac AL amyloidosis].
Rinsho Ketsueki
; 58(11): 2197-2204, 2017.
Artículo
en Japonés
| MEDLINE | ID: mdl-29212969
12.
Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma.
Br J Haematol
; 186(2): 355-358, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859556
13.
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA.
Br J Haematol
; 185(5): 969-974, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30474853
14.
Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study.
BMJ Support Palliat Care
; 14(2): 195-199, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38569748
15.
Acute accumulation of PIM2 and NRF2 and recovery of ß5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
Int J Hematol
; 119(3): 303-315, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38245883
16.
Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.
Br J Haematol
; 180(4): 581-585, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27748523
17.
Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice.
Int J Hematol
; 117(5): 718-728, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36692689
18.
Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation.
J Cancer Surviv
; 17(3): 781-794, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36048313
19.
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase.
Blood Adv
; 7(6): 1019-1032, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36129197
20.
Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate.
J Bioenerg Biomembr
; 44(1): 31-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22298254